Skip to main content

购买 Geftinat | Ge Geftinat 药

Depict 
Geftinat Katagiri Dairy Acid Rising Crisis. 
Geftinat-containing aptly non-alternative active ingredient,
 Acupuncture physical distribution epidermal growth factor recipient dairy acid hyper-accumulative inhibition.
Geftinat 
剂 适 ef Geftinat 剂 疗 适应 晚 细 细 细 的 的 线.
Geftinat's main anchor point,
In non-small cell lung cancer patients with non-small cell lung cancer, non-small cell lung cancer patients excluded forceps 19 loss or external forceps 21 modified outside, 其 EGFR 其.
Geftinat 
anti- collision action Geftinat cut-off anti-cancer drug, anti-collision appearance anti-aneurysm cystic anti-aneurysm active mechanism.
非 过 过 于 于 于 细 细 表面 表面 Epidermal growth factor receptor on the surface. Necessary to use a signal for acupuncture and moxibustion.
Inaba, recipient blockage abscission prohibited abscission, angiogenesis and WC death.
Geftinat 剂 ADME 口 生物
: Bioavailability
: 60%, 食物 食物, 变, 胃 pH 胃 pH 非 生物 生物. 值 pH 值> 5, 则 cause 47 47%.
Blood pressure peak time: 3 to 7 hours
Good luck alternative distribution capacity 为 1400 ~ 1600 L
Human blood protein combination: 90%
谢 通 谢 脏 发生, 产生 性 性 OO- 基基吉 不 尼
Cleared <4% in urine through; 86% stools
非 不 尼 的 为 30.5 小时 至 41 小时
Yoshino replacement clean 500ml / min
Bioavailability: 60%, Absence of food natural hatching; Stomach pH modified Ji-Ye non-alterative bioavailability. 值 pH 值> 5, 则 cause 47 47%.
Blood pressure peak time: 3 to 7 hours
Good luck alternative distribution capacity 为 1400 ~ 1600 L
Human blood protein combination: 90%
谢 通 谢 脏 发生, 产生 性 性 OO- 基基吉 不 尼
Cleared <4% in urine through; 86% stools
非 不 尼 的 为 30.5 小时 至 41 小时
Yoshino replacement clean 500ml / min
Geftinat one-shot dose: 250 mg single dose;
Geftinat is a part of food and food.
Patient unbearable oral cavity,
Geftinat Katagiri dispersed water, dose 为 4 to 8 盎
After complete dissolution, use it immediately or for nasogastric fistula.
Standing following conditions hold Geftinat Kata剂: 
lung portion symptoms爆发certain恶化
ALT sum AST horizontal squares high
belly泻加剧恶of
skin肤反应
standing following information况下stop for Geftinat Kata剂: 
Kankono damages严重恶化
stomach肠穿hole
ulcerative keratitis
间质Lung disease
Geftinat piece amount 剂
对于 对于 过 amount condition, 
条件有别的 疗 方法. Patients with specific needs, 
specific supportive measures given regular support concurrency symptoms.
Geftinat-Katto-Guen-Tat interaction 
Geftinat-CYP3A4 combined abstain abduct non-abductor abductor abductor abductor abduct
Geftinat combined CYP3A4 inhibition abduction Ji non-commutative alternative abduction
Geftinat after-gastric pH, free fall and low non-replacement blood clotness
Geftinat 华 增 增 不良 效, 这 以 过 频 监测 时 IN IN IN IN INR 避 避.
During the treatment period of Geftinat, sterility dose 葡萄 导 非 非 升 height.
Geftinat piece剂副action 
platelet减少
严重atrial颤动
QT Prolongation
vascular water Myeloma
week围水Myeloma
body weight减轻
skin肤干燥
坏死pine solution disease
polymorphic红斑
exfoliative skin dermatitis
finger instep disorderly
增加AST sum ALT
厌食disease
恶心
胰腺flame
oral dermatitis
conjunctivitis flame
abdominal pain
间质sex lung
Hara泻
stomach肠穿hole
Geftinat piece预防措施
resident间质pulmonary disease in:如果patient获得ILD, Geftinat Kata剂for certain stop for stopping immediately请立.
Hepatotoxicity: If AST plus ALT horizontal depression height, abducted hepatotoxication, evasion and cessation cessation stop use Yoshi non replacement treatment.
Gastric fistula perforation: Permanent stop treatment.
Pain: Stop or Stop Treatment
Eye disease: If you have an eye disease, acupuncture arrest treatment or permanent arrest treatment.
Proteus-sum-exfoliated pruritus: Geftinat cleavage, available under conditions, available, stopped or suspended.
Embryonal pregnancy: Geftinat use condition under pregnancy condition. Reconciliation and maternity evacuation
Geftinat's existence condition 
chess item existence 200C-250C.
Child
Our 联 + 
919987711567
info@applepharma.cn

Comments

Popular posts from this blog

Comprar Tagrisso 80mg | Precio Tagrisso 80mg medicina

DESCRIPCIÓN Una tableta de Tagrisso de 80 mg contiene un principio activo conocido como Osimeritinib, que antes se conocía como Mereletinib.Tagrisso 80 mg está considerado como medicamento de tercera generación, que está disponible en forma de tableta.Tagrisso 80 mg es un inhibidor inevitable del receptor del factor de crecimiento epidérmico, desviado de manera selectiva, que contiene actividad anticancerígena. La categoría farmacológica de Tagrisso 80mg es tirosina quinasa prohibitor. INDICACIÓN Un comprimido de Tagrisso 80 mg (osimertinib) está ampliamente indicado como tratamiento de primera línea para el cáncer de pulmón no microcítico avanzado con pacientes con mutación EGFR positiva.Tagrisso 40mgi s también se utiliza para el tratamiento de pacientes afectados con una mutación positiva de EGFR T792M NSCLC, la enfermedad ha avanzado en o después del tratamiento con inhibidores de la tirosina quinasa.Usos en Embarazo, lactancia, pediatría: No se asigna la categoría de embara

Trastuzumab - Biceltis 440mg injection online | Myapplepharma

Biceltis 440 mg Injection             Biceltis 440mg is a group of medicines which belongs to anti neoplastic medication. Biceltis is a chemotherapy drug. It is recommended that Biceltis 440mg be administered under the guidance of a qualified physician experienced in the use of cancer chemotherapeutic agents. USES           The injection Biceltis 440mg is used alone or combination with other medicine for the treatment in patients who suffering from metastatic breast cancer.           The drug also indicated with combination of other medicine for the treatment of certain types of stomach or esophagus cancer in some persons. WORK AS         Different type of breast cancer cells has a higher than normal level of a protein called HER2 (human epidermal growth factor receptor 2) on their surface. These HER2 receptors get signals which stimulate the tumor cells to develop and reproduce. But breast cancer cells with too many HER2 receptors can Choice too many growth signa

Купить Erlonat 150 | Erlonat 150 цена 150 $

ОПИСАНИЕ Erlonat 150мг  таблетки состоят из активных ингредиентов, известных как Erlotinib (Generic Tarceva) , который считается производным хиназолина и противораковые агенты, которые отвечают как ингибиторы протеинкиназы на EGFR, связанные с тирозинкиназой. Erlonat 150мг в основном используется в лечение немелкоклеточного рака легких и рака поджелудочной железы, а также участие в лечении различных видов рака. Эрлонат особенно нацелен эпидермальный фактор роста, рецепторная тирозинкиназа. ИСПОЛЬЗОВАНИЕ Erlonat Немелкоклеточный рак легких: Эрлонат показан в качестве продолжения терапии у пациентов с длительной или метастазирующей немелкоклеточной карциномой легкого, чье заболевание имеет не получить аванс после четырех циклов терапии с использованием первой линии на основе платины. Erlonat используется в этом состоянии только после отказа одного из предыдущих режим химиотерапии. При использовании Erlonat 150мг с такими соединениями на основе платины, как карбоплатин, гемцитаби